Skip to main content
Mainz Biomed N.V. (MYNZ)
NASDAQ: MYNZ · Real-Time Price · USD
0.810
-0.020 (-2.40%)
At close: Mar 9, 2026, 4:00 PM EDT
0.857
+0.047 (5.79%)
After-hours: Mar 9, 2026, 7:53 PM EDT

Mainz Biomed Revenue

Mainz Biomed had revenue of $286.72K in the half year ending June 30, 2025, a decrease of -42.55%. This brings the company's revenue in the last twelve months to $659.94K, down -28.05% year-over-year. In the year 2024, Mainz Biomed had annual revenue of $893.99K, down -0.17%.

Revenue (ttm)
$659.94K
Revenue Growth
-28.05%
P/S Ratio
13.25
Revenue / Employee
$25,382
Employees
26
Market Cap
8.75M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024893.99K-1.49K-0.17%
Dec 31, 2023895.48K365.60K69.00%
Dec 31, 2022529.88K-47.47K-8.22%
Dec 31, 2021577.35K83.78K16.98%
Dec 31, 2020493.57K212.17K75.40%
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Inotiv 514.03M
MDxHealth 107.88M
FONAR 106.03M
Exagen 63.60M
XWELL 29.52M
Precipio 22.80M
bioAffinity Technologies 6.78M
iSpecimen 3.35M
Revenue Rankings

MYNZ News

More News